share_log
Moomoo 24/7 ·  Feb 29 10:45
Ironwood Pharmaceuticals Shares Are Trading Lower After the Company's Phase 3 Trial of Once-weekly Subcutaneous Apraglutide Did Not Meet Two Out of Four Key Secondary Endpoints
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment